November 2012
Malaria, Malaria
October 2012
Antibiotic Resistance, Malaria
Has AMFm been effective? How will it continue in the future?Read more
October 2012
Malaria, Antibiotic Resistance
What broad-based economic solutions could help fight the growing threat of antibiotic resistance?Read more
April 2012
Malaria, Malaria
Why have there been so many historical failures to maintain gains in malaria control?Read more
September 2011
Antibiotic Resistance, Malaria
August 2011
Malaria, Antibiotic Resistance
This report surveys antibiotic use and resistance in Kenya and offers actionable policy proposals to lessen the burden of bacterial infections in the country.Read more
March 2011
Malaria, Antibiotic Resistance
Antimicrobial stewardship programs (ASPs) have expanded in the past decade. What are the characteristics of current ASPs and what barriers remain to their implementation?Read more
March 2011
Malaria, Antibiotic Resistance
December 2010
Antibiotic Resistance, Malaria
December 2010
Antibiotic Resistance, Malaria, Health and Development
In examining potential short-term to medium-term financial savings, what are the marginal costs and benefits of converting malaria programmes from a control to an elimination goal?Read more
November 2010
Malaria, Malaria
What is the cost-effectiveness of an intervention to supply prereferral rectal artesunate to children with suspected malaria?Read more
November 2010
Malaria, Health and Development, Malaria
What strategies best support malaria elimination, taking into account both transmission within an endemic country and imported cases of the disease?Read more
November 2010
Antibiotic Resistance, Malaria
What is the relative feasibility of eliminating malaria across malaria-endemic countries?Read more
August 2010
Antibiotic Resistance, Malaria
Limiting the spread of antimalarial resistance is one of the key rationales motivating ACT deployment, but surprisingly little research has been conducted on the spread of antimalarial resistance following large-scale ACT deployment. This study reports on the large-scale surveillance of dhfr and...Read more
August 2010
Malaria, Malaria
Multiple first-line therapies (MFT) have the potential to decrease mortality and morbidity while maximizing the useful therapeutic life of ACTs by delaying the development of drug resistance. However, the effectiveness and success of any strategy will also depend on the financial and operational...Read more
August 2010
Malaria, Malaria
There is strong evidence to support the implementation of multiple first-line therapies (MFTs) to delay the evolution of anti-malarial drug resistance, particularly given the uncertainty about timeline for the emergence of such resistance.Read more
June 2010
Malaria, Malaria
The mapping here of both communities of countries linked by likely higher levels of infection movement, and natural migration boundaries that display reduced movement of people and infections between regions has practical utility. These maps can inform the design of malaria elimination strategies...Read more
June 2010
Malaria, Malaria
June 2010
Malaria, Antibiotic Resistance
May 2010
Malaria, Malaria
May 2010
Malaria, Malaria
Resources for the Future (RFF) convened a Forum of operational experts, scientists, economists, and policymakers to consider the best available evidence to address issues still of concern to some stakeholders regarding the large-scale implementation of the Affordable Medicines Facility-malaria(AMFm...Read more
May 2010
Malaria, Environmental Health
Using data from a Jakarta household survey, we estimate a model of household defensive behavior and illness allowing for some risk factors that are hidden to the analyst but, perhaps, known to the household. As predicted by a general preference-based theoretical model, defensive behavior (washing...Read more
May 2010
Malaria, Malaria
This study measures the monetary value households place on preventing malaria in Tigray, Ethiopia. We estimate a household demand function for a hypothetical malaria vaccine and compute the value of preventing malaria as the household's maximum willingness to pay to provide vaccines for all...Read more
May 2010
Malaria, Environmental Health
May 2010
Malaria, Antibiotic Resistance
Risk factors for the nosocomial recovery of imipenem-resistant Pseudomonas aeruginosa (IRPA) were determined. A case-control study design was used for the comparison of 2 groups of case patients with control patients. The first group of case patients had nosocomial isolation of IRPA, and the second...Read more
May 2010
Malaria, Antibiotic Resistance
The increasing resistance of harmful biological organisms (bacteria, parasites, and pests) to selection pressure from the widespread use of control agents such as antibiotics, antimalarials, and pesticides is a serious problem in both medicine and agriculture. Modeling resistance or, conversely,...Read more
May 2010
Alcohol and Tobacco, Malaria
Malaria treatment has long relied on chloroquine, but in a world of increasing resistance, which alternative treatment should replace this failing drug?Read more
May 2010
Disease Control Priorities, Malaria
Since its introduction in the 1950s, chloroquine has been the mainstay of malaria treatment worldwide. Costing only a few cents a dose, its fever-fighting qualities have also been valuable for unrelated illnesses. Over time, malaria parasites have become resistant to the drug, and this resistance...Read more
May 2010
Malaria, Antibiotic Resistance
